Reducing pediatric HIV infection: Estimating mother-to-child transmission rates in a program setting in Zambia

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 4, 2010, Pages 415-422

  Torpey, Kwasi ^a   Kasonde, Prisca ^a   Kabaso, Mushota ^a   Weaver, Mark A ^b   Bryan, Gail ^a   Mukonka, Victor ^c   Bweupe, Maximillian ^c   Zimba, Chilunje ^a   Mwale, Felicitas ^a   Colebunders, Robert ^d  

^a Zambia Prevention Care and Treatment Partnership   (Zambia)

^b Quantitative Sciences   (United States)

^c MINISTRY OF HEALTH   (Zambia)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

effectiveness; PCR; PMTCT; transmission rates; vertical transmission; Zambia

Indexed keywords

NEVIRAPINE; ZIDOVUDINE; VIRUS DNA;

ARTICLE; BREAST FEEDING; FEMALE; FETUS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERINATAL INFECTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ZAMBIA; ARTIFICIAL MILK; CHILD; DISEASE TRANSMISSION; DRUG COMBINATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOTHER CHILD RELATION; NEWBORN; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RISK;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; CHILD; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MOTHER-CHILD RELATIONS; NEVIRAPINE; ODDS RATIO; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; ZAMBIA; ZIDOVUDINE;

EID: 77955503258     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e36616     Document Type: Article

References (21)

1. UNAIDS/WHO. AIDS Epidemic Update. December 2008. Geneva: UNAIDS; 2008.
2. UNICEF. State of the World's Children 2008. New York: UNICEF 2008.
3. De Cock K, Fowler MG, Mercier E, et al. Prevention of mother-to-child transmission in resource poor countries: translating research to policy and practice. JAMA. 2000;283:1175-1182.
4. National AIDS Council/GRZ/Ministry of Health. National Protocol Guidelines: Integrated Prevention of Mother-to-Child Transmission of HIV. Lusaka, Zambia: Ministry of Health; 2008.
5. United Nations Children's Fund/Joint United nations Programs on HIV/AIDs/World\Health Organization. Towards Universal Access, Scaling up HIV Services for Women and Children in the Health Sector: Progress Report 2008. Geneva, Switzerland: WHO 2008.
6. Benjamin DK, Miller DC, Fiscus SA, et al. Rational testing of the HIV exposed infant. Pediatrics. 2001;108:e3.
7. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of polymerase chain reaction for the detection of HIV 1 infection in neonates. AIDS. 1995;9: 7-11.
8. Sherman GG, Stevens WS, Stevens G, et al. Diagnosis of human immunodeficiency virus infection in perinatally exposed orphaned infants in a resource poor setting. Pediatr Infect Dis J. 2000;19:1014-1015.
9. Sherman GG, Jones SA, Coovadia AH, et al. PMTCT from research to reality-results from a routine service. S Afr Med J. 2004;94:289-292.
10. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet. 1999;354:795-802.
11. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized control trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early post partum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003; 187:725-735.
12. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. 18 month follow up of HIV-NET 012 randomized trial. Lancet. 2003;362:859-868.
13. Dabis F, Bequet L, Ekouevi EK, et al. Field efficacy of zidovudine, lamivudine and single dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005;19:309-318.
14. Creek T, Tanuri A, Smith M, et al. Early diagnosis of human immunodeficiency virus using polymerase chain reaction on dried blood spot in Botswana's National Program on Prevention of Mother-to-Child Transmission. Pediatr Infect Dis J. 2008;27:22-26.
15. Mnyani C, McIntyre J, Struthers H, et al. Reducing PMTCT in practice: results from a successful model of a PMTCT program in a high prevalence HIV urban setting. Abstract #TUPEC048. Presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22 2009; Cape Town, South Africa.
16. Stringer JS, Sinkala M, Maclean CC, et al. Effectiveness of a city wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS. 2005;19:1309-1315.
17. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infections in Infants in Resource Limited Settings: Towards a Universal Access. 2006 Version. Geneva: WHO; 2006.
18. Thior I, Lockman S, Smeaton L, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs. formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana. A randomized trial: Mashi Study. JAMA. 2006;296:794-805.
19. Kumwenda N, Hoover D, Mofenson L, et al. Extended antiretroviral prophylaxis to reduce breast milk HIV-1 transmission. N Eng J Med. 2008;359:119-129.
20. SWEN Study Team. Extended dose of Nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India and Uganda: an analysis of three randomized control trials. Lancet. 2008; 372:300-313.
21. Shapiro R, Hughes M, Ogwu A, et al. A randomized trial comparing highly active antiretroviral therapy regimens for virologic efficacy and prevention of mother child HIV transmission among breast feeding women in Botswana. Presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa. Abstract #WELBB101.